Effects of combined valproic acid and the epidermal growth factor/vascular endothelial growth factor receptor tyrosine kinase inhibitor AEE788 on renal cell carcinoma cell lines <i>in vitro</i>

Eva Juengel, Johanna Engler, Ausra Mickuckyte, Jon Jones, Lukasz Hudak, Dietger Jonas, Roman A. Blaheta

British Journal of Urology · 2009 · 21 citations · 29 references

Abstract

Both AEE788 and VPA profoundly block the interaction of RCC cells with endothelium and extracellular matrix and reduce tumour growth in vitro. Therefore, this combined regimen warrants further preclinical and possible clinical study for treating advanced RCC.

References

29